Back
April 25, 2022

The immunological rationale against C-19 vaccination of children

When a deep understanding of immunology, virology, vaccinology, evolutionary biology, and molecular biology is applied to analysis of whether children should receive current vaccines against COVID-19 (C-19), it is concluded that recommendation of such vaccination is scientifically unsound and that such vaccination is harmful to individual children, children as a group, and Humanity as a whole, for the following reasons:

  1. children have an abundant population of innate B cells that are capable of rapidly producing innate / natural antibodies (Abs), mostly of IgM isotype, and that are highly adaptable to a broad and diversified spectrum of antigens or pathogenic agents. Innate Abs can facilitate cell-mediated killing of host cells infected with Coronaviruses (CoVs), including all SC-2 variants, independently of previous immune priming by antigen / pathogen encounters.
  2. innate immunity can be trained such as to acquire memory and, therefore, improve the host’s innate immune defense upon future exposure to more infectious variants that may emerge during an epidemic or pandemic.
  3. the C-19 vaccines undermine the innate immune system by, for example, hindering binding of innate, low affinity antibodies and by interfering with the normal training of a child’s innate immune system.  

Support our work
DONATE
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.

Email: info@voiceforscienceandsolidarity.org

Recent Posts
May 25, 2022

VSS Scientific Updates During Pandemic Times #22

Read
May 23, 2022

VSS Scientific Updates During Pandemic Times #21

Read
May 17, 2022

Q&A #13: Why do Public Health authorities continue to promote C-19 vaccination of children?

Read
Voices for Science and solidarity, © 2021